David Joseph Topper Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

David Joseph Topper is Chief Financial Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 182,774 shares of ARQT, which is worth approximately $2.88 Million. The most recent transaction as insider was on Apr 02, 2025, when has been sold 9,600 shares (Common Stock) at a price of $15.8 per share, resulting in proceeds of $151,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K

15.41% 3M change

n/a 12M change

Total Value Held $2.88 Million

David Joseph Topper Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 02 2025	SELL Open market or private sale	$151,680 $15.8 p/Share	9,600 Reduced 4.99%	182,774 Common Stock
Feb 28 2025	BUY Grant, award, or other acquisition	-	34,000 Added 15.02%	192,374 Common Stock
Sep 24 2024	SELL Open market or private sale	$110,214 $9.48 p/Share	11,626 Reduced 6.84%	158,374 Common Stock
Sep 21 2024	BUY Grant, award, or other acquisition	-	60,000 Added 26.09%	170,000 Common Stock
Apr 10 2024	BUY Grant, award, or other acquisition	-	110,000 Added 50.0%	110,000 Common Stock

Also insider at

FLAC

Frazier Lifesciences Acquisition Corp Financial Services

Chief Financial Officer

DJT